Associate Director - Tech@Lilly Automation Technical Lead at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

  • Incident Management & Response for RPA bots (60-70% of role): Monitor system health, troubleshoot issues, and respond to incidents to minimize downtime in support of RPA portfolio
  • Automation & Infrastructure as Code and System Reliability & Performance (30-40% of role): Ability to independently develop scripts and automation tools for deployment, monitoring, and infrastructure management to maintain high availability and performance of production systems
  • Strong problem solving and analytical skills and highly adaptable to changing circumstances
  • Experience in reliability engineering and monitoring practices, environments, and tools (e.g., cloud ecosystem)
  • Expertise in RPA as a Platform Leader
  • Object-oriented development skills
  • Ability to work in ambiguity and accept failure
  • Superb communicator with strong interpersonal skills to collaborate effectively on a team, including with remote team members
  • Innovative and curious about new technology for business process efficiency

Responsibilities

  • Maintain and support critical robotic process automation (RPA) portfolio
  • Reduce support footprint through automation and observability
  • Create reusable application components with intent toward self-service
  • Engage in software development and system engineering related activities
  • Collaborate within Global Business Services to promote reliability engineering during all phases of the software lifecycle to detect and correct performance issues across current portfolio, finding optimizations or reductions in RPA use where possible
  • Identify, assess, and reduce support footprint by recommending and implementing automation and observability practices
  • Proactively influence development to enable long-term growth and lead the organization in new development to ensure optimization in end-to-end application lifecycle support
  • Monitor service level objectives (SLOs) to support system operations and ROI through dashboard development and KPI tracking
  • Define and champion reliability engineering practices among engineering and product teams, participate in communities of practice, and mentor others through collaboration
  • Create AiOps, workflows, and utility scripts published as IaC (Infrastructure as Code) to reduce hands-on support needs long-term
  • Work and collaborate effectively on a team to define, design, and deliver new features, ensuring execution and implementation support the enterprise roadmap

Skills

RPA
Automation
AI
Reliability Engineering
Observability
Software Development
System Engineering

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI